STRS Ohio’s Coherus Oncology CHRS Stock Holding History

STRS Ohio’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$554K	Buy	395,600 +71,600	+22%	+$117K	﹤0.01%	1096
2026 Q1	$548K	Hold	324,000	–	–	﹤0.01%	1033
2025 Q4	$460K	Hold	324,000	–	–	﹤0.01%	1139
2025 Q3	$531K	Hold	324,000	–	–	﹤0.01%	1056
2025 Q2	$237K	Hold	324,000	–	–	﹤0.01%	1609
2025 Q1	$261K	Hold	324,000	–	–	﹤0.01%	1440
2024 Q4	$447K	Sell	324,000 -19,400	-6%	-$21.8K	﹤0.01%	1248
2024 Q3	$357K	Buy	343,400 +248,800	+263%	+$341K	﹤0.01%	1396
2024 Q2	$164K	Buy	+94,600	New	+$190K	﹤0.01%	1603
2023 Q1	–	Sell	-30,300	Closed	-$239K	–	1963
2022 Q4	$239K	Sell	30,300 -9,200	-23%	-$70.8K	﹤0.01%	1544
2022 Q3	$379K	Hold	39,500	–	–	﹤0.01%	1431
2022 Q2	$285K	Buy	39,500 +2,200	+6%	+$19.1K	﹤0.01%	1501
2022 Q1	$481K	Sell	37,300 -2,500	-6%	-$31.8K	﹤0.01%	1453
2021 Q4	$635K	Hold	39,800	–	–	﹤0.01%	1398
2021 Q3	$639K	Hold	39,800	–	–	﹤0.01%	1411
2021 Q2	$550K	Sell	39,800 -18,900	-32%	-$268K	﹤0.01%	1529
2021 Q1	$857K	Buy	58,700 +10,800	+23%	+$183K	﹤0.01%	1269
2020 Q4	$832K	Buy	47,900 +45,400	+1,816%	+$808K	﹤0.01%	1174
2020 Q3	$45K	Buy	+2,500	New	+$46.5K	﹤0.01%	1987
2016 Q4	–	Sell	-600	Closed	-$16K	–	1928
2016 Q3	$16K	Hold	600	–	–	﹤0.01%	1851
2016 Q2	$10K	Hold	600	–	–	﹤0.01%	1885
2016 Q1	$12K	Hold	600	–	–	﹤0.01%	1845
2015 Q4	$13K	Buy	+600	New	+$15.4K	﹤0.01%	1870
2015 Q1	–	Sell	-2,400	Closed	-$62K	–	1813
2014 Q4	$39K	Buy	+2,400	New	+$33.9K	﹤0.01%	1639

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

STRS Ohio's CHRS Position: Q2 2026 in Review

STRS Ohio increased its Coherus Oncology (CHRS) stake by 22% in Q2 2026, buying an estimated $117K and bringing the position to 395,600 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

STRS Ohio first reported a position in CHRS in Q4 2014 and has held it in 24 quarters since. The position peaked at $857K in Q1 2021. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

STRS Ohio held 395,600 shares of Coherus Oncology worth $554K as of Q2 2026.
STRS Ohio bought 71,600 Coherus Oncology shares in Q2 2026, an estimated $117K.
Coherus Oncology made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1096 holding.
STRS Ohio first reported a position in Coherus Oncology in Q4 2014 and has held it in 24 quarters since.
STRS Ohio's Coherus Oncology position peaked at $857K in Q1 2021.
147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.